Filomena Paci Josefina, García Alfaro Marta, Redondo Alonso Francisco Javier, Fernández San-Martín María Isabel
Centro de atención primaria El Clot, Institut Català de la Salut, Barcelona, España.
Centro de atención primaria La Mina, Institut Català de la Salut, Barcelona, España.
Aten Primaria. 2015 Jan;47(1):38-47. doi: 10.1016/j.aprim.2014.03.013. Epub 2014 Aug 10.
To describe inappropriate prescribing (IP) in the polymedicated population over 64 years-old in primary care using the STOPP/START criteria.
The study design was descriptive, cross-sectional and multicenter.
Four urban primary care centers in Barcelona. Participants Patients over 64 years-old with more than 5 prescribed drugs for at least 6 months (n=467). Main measurements Major health problems, chronically prescribed drugs, and percentage of IP using the STOPP/START criteria were studied. Percentage of IP considered as the percentage of patients with at least one STOPP or START non-compliance criterion was calculated with a 95%CI. Chi-square was used for statistical analysis.
The mean age was 77.3 (± 7.0 SD) with a mean of 8.9 (± 2.8 SD) prescribed drugs. IP was higher the greater the number of drugs prescribed (p<0,01). 326 patients (76.4% [95%CI: 72.2 to 80.6]) had at least one IP, according to STOPP/START criteria. STOPP IP affected 51.4% of the patients and START IP 53.6%. The most frequent causes of IP were antiplatelet agents, for both over-prescribing (10.2%) and omission (17.9%). Prolonged use of benzodiazepines (6.6%) and duplications (6.4%) followed in prevalence.
IP in polymedicated patients in primary care was very high. IP was similar for drugs that should be withdrawn or started. The most common causes of IP were antiplatelet agents, benzodiazepines and drug duplication.
使用STOPP/START标准描述初级保健中64岁以上多药治疗人群的不适当处方(IP)情况。
本研究设计为描述性、横断面和多中心研究。
巴塞罗那的四个城市初级保健中心。参与者为64岁以上且至少6个月内服用5种以上处方药的患者(n = 467)。主要测量指标研究了主要健康问题、长期服用的药物以及使用STOPP/START标准的IP百分比。将IP百分比计算为至少有一项STOPP或START不符合标准的患者百分比,并给出95%置信区间。采用卡方检验进行统计分析。
平均年龄为77.3岁(标准差±7.0),平均处方药数量为8.9种(标准差±2.8)。处方药物数量越多,IP越高(p<0.01)。根据STOPP/START标准,326名患者(76.4%[95%置信区间:72.2至80.6])至少有一项IP。STOPP IP影响了51.4%的患者,START IP影响了53.6%的患者。IP最常见的原因是抗血小板药物,包括处方过量(10.2%)和遗漏(17.9%)。苯二氮䓬类药物的长期使用(6.6%)和重复用药(6.4%)在患病率上紧随其后。
初级保健中多药治疗患者的IP非常高。对于应停用或开始使用的药物,IP情况相似。IP最常见的原因是抗血小板药物、苯二氮䓬类药物和药物重复。